menu
    • menu

    Company profile for Metacrine

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biopharmaceutical company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal, or GI, diseases. Our most advanced program is focused on the farnesoid X receptor (FXR) an important drug target in multiple liver and GI diseases. We have leveraged our chemistry and biology platform to internally discover a proprietary portfolio of non-bile acid FXR agonists...
    We are a clinical-stage biopharmaceutical company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal, or GI, diseases. Our most advanced program is focused on the farnesoid X receptor (FXR) an important drug target in multiple liver and GI diseases. We have leveraged our chemistry and biology platform to internally discover a proprietary portfolio of non-bile acid FXR agonists. We purposefully design our product candidates, to be optimized, next-generation FXR agonists that we are initially developing as a differentiated and best-in-class treatment for nonalcoholic steatohepatitis (NASH).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MetacrineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3985 Sorrento Valley Blvd., Suite C San Diego, CA 92121
    Telephone
    Telephone
    (858) 369-7800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://metacrine.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Equillium is no longer buying Metacrine, citing new cash
    Equillium is no longer buying Metacrine, citing new cash

    27 Dec 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/equillium-cancels-metacrine-buy-citing-strong-financial-position-after-ono-deal

    Max Bayer FIERCEBIOTECH
    27 Dec 2022
    Share Share
    Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
    Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement

    23 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/23/2579251/0/en/Metacrine-and-Equillium-Mutually-Agree-to-Terminate-Definitive-Merger-Agreement.html

    GLOBENEWSWIRE
    23 Dec 2022
    Share Share
    Equillium to Acquire Metacrine in All-Stock Transaction
    Equillium to Acquire Metacrine in All-Stock Transaction

    06 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220906005973/en

    BUSINESSWIRE
    06 Sep 2022
    Share Share
    Metacrine Reports First-Quarter 2022 Results
    Metacrine Reports First-Quarter 2022 Results

    12 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/12/2442445/0/en/Metacrine-Reports-First-Quarter-2022-Results.html

    GLOBENEWSWIRE
    12 May 2022
    Share Share
    Metacrine Reports Fourth-Quarter 2021 Results
    Metacrine Reports Fourth-Quarter 2021 Results

    30 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/30/2413247/0/en/Metacrine-Reports-Fourth-Quarter-2021-Results.html

    GLOBENEWSWIRE
    30 Mar 2022
    Share Share
    Metacrine Announces Executive Leadership Changes
    Metacrine Announces Executive Leadership Changes

    24 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/24/2391908/0/en/Metacrine-Announces-Executive-Leadership-Changes.html

    GLOBENEWSWIRE
    24 Feb 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search